ProMIS Neurosciences Inc. (PMN) Analysts See $-0.01 EPS; Asure Software, Inc. (ASUR) Covered By 9 Bulls

February 15, 2018 - By Adrian Erickson

Analysts expect ProMIS Neurosciences Inc. (TSE:PMN) to report $-0.01 EPS on March, 21.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.01 EPS. After having $-0.01 EPS previously, ProMIS Neurosciences Inc.’s analysts see 0.00% EPS growth. The stock decreased 3.77% or $0.02 during the last trading session, reaching $0.51. About 961,049 shares traded. ProMIS Neurosciences Inc. (TSE:PMN) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 9 analysts covering Asure Software (NASDAQ:ASUR), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Asure Software had 21 analyst reports since August 14, 2015 according to SRatingsIntel. On Thursday, September 21 the stock rating was maintained by Northland Capital with “Buy”. The stock has “Buy” rating by Lake Street on Monday, October 17. Roth Capital maintained the stock with “Buy” rating in Tuesday, October 3 report. The stock of Asure Software, Inc. (NASDAQ:ASUR) earned “Buy” rating by Cowen & Co on Tuesday, December 19. Wunderlich initiated Asure Software, Inc. (NASDAQ:ASUR) rating on Friday, October 28. Wunderlich has “Buy” rating and $12 target. Northland Capital maintained Asure Software, Inc. (NASDAQ:ASUR) rating on Tuesday, November 17. Northland Capital has “Outperform” rating and $7 target. The company was maintained on Friday, October 13 by Cowen & Co. The stock of Asure Software, Inc. (NASDAQ:ASUR) earned “Buy” rating by Roth Capital on Monday, July 17. Barrington Research maintained it with “Outperform” rating and $10 target in Tuesday, November 1 report. The rating was maintained by Roth Capital with “Buy” on Friday, June 2. See Asure Software, Inc. (NASDAQ:ASUR) latest ratings:

02/01/2018 Broker: Roth Capital Rating: Buy New Target: $23.0 Maintain
19/12/2017 Broker: Cowen & Co Rating: Buy New Target: $20.0 Maintain
04/12/2017 Broker: Craig Hallum Rating: Buy New Target: $19.0 Initiate
14/11/2017 Broker: Northland Capital Rating: Buy New Target: $18.0 Maintain
31/10/2017 Broker: Dougherty Rating: Buy New Target: $17 Initiates Coverage On
13/10/2017 Broker: Cowen & Co Rating: Buy New Target: $16.0 Maintain
03/10/2017 Broker: Roth Capital Rating: Buy New Target: $20.0 Maintain
21/09/2017 Broker: Northland Capital Rating: Buy New Target: $18.0 Maintain
06/09/2017 Broker: Cowen & Co Rating: Outperform New Target: $16 Initiates Coverage On

Investors sentiment decreased to 2 in 2017 Q3. Its down 1.50, from 3.5 in 2017Q2. It fall, as 5 investors sold Asure Software, Inc. shares while 7 reduced holdings. 7 funds opened positions while 17 raised stakes. 4.90 million shares or 40.81% less from 8.27 million shares in 2017Q2 were reported. Awm Inv holds 274,667 shares or 0.6% of its portfolio. Oberweis Asset Mgmt Inc invested in 82,381 shares. Wells Fargo And Mn owns 61,750 shares. California Public Employees Retirement Sys reported 0% in Asure Software, Inc. (NASDAQ:ASUR). Blackrock reported 125,116 shares or 0% of all its holdings. Us-based Ancora Advisors Lc has invested 0.08% in Asure Software, Inc. (NASDAQ:ASUR). Prudential Plc holds 0.01% or 330,000 shares in its portfolio. Fmr Ltd Limited Liability Company reported 86,417 shares stake. Jfs Wealth Advsr Limited reported 8 shares. Argent Capital Mngmt Limited Liability Co holds 136,175 shares. Vanguard Group Incorporated reported 0% stake. Deutsche Savings Bank Ag reported 59,096 shares. Catalyst Capital Advsr Lc holds 0.03% or 47,600 shares. Eam Limited Liability reported 40,846 shares. Northern reported 24,419 shares.

Asure Software, Inc. provides cloud software-as-a-service time and labor management, and workspace management solutions worldwide. The company has market cap of $170.05 million. The firm offers a suite of solutions to help clients optimize and manage their mobile workforces and their global workspaces. It currently has negative earnings. The Company’s SaaS offerings include asset management, mobile room scheduling, mobile time tracking, scheduling software, space utilization solutions, tablet time clocks, time and labor management software, traditional time clocks, touch panels for room scheduling, and workplace business intelligence analytics.

The stock decreased 0.07% or $0.01 during the last trading session, reaching $13.64. About 2,483 shares traded. Asure Software, Inc. (NASDAQ:ASUR) has risen 137.62% since February 15, 2017 and is uptrending. It has outperformed by 120.92% the S&P500.

ProMIS Neurosciences Inc., a development stage biotech company, discovers and develops precision medicine therapeutics for treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company has market cap of $112.23 million. The Company’s proprietary target discovery engine is based on the use of two complementary techniques. It currently has negative earnings. The firm applies its thermodynamic, computational discovery platform?ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>